Latest News - Acquisitions and Mergers

Tuesday, March 26, 2019

Allergan Acquires Envy Medical, Inc.

Allergan now owns Envy Medical, Inc.  The acquisition adds Envy's Dermalinfusion, a non-surgical, non-invasive skin resurfacing system for the face and body, to Allergan's portfolio. O…

Read the full story

Monday, March 25, 2019

Biofrontera Acquires Cutanea Life Sciences

Biofrontera Inc., USA entered into an agreement to acquire all shares in Cutanea Life Sciences, Inc., USA through its subsidiary Biofrontera Newderm LLC as the acquirer, with Maruho Co., Ltd., Japan a…

Read the full story

Friday, March 15, 2019

Constellation Alpha Capital Corp. Signs Letter of Intent to Acquire DermTech, Inc.

Constellation Alpha Capital Corp., a special purpose acquisition company, has executed a non-binding Letter of Intent to merge with DermTech, Inc., a molecular genomics company with an initial focus o…

Read the full story

Monday, January 14, 2019

L’Occitane to Buy ELEMIS for $900 Million

L’Occitane International S.A. has entered into a definitive agreement to acquire ELEMIS, the number one luxury British skincare brand, for $900 million in cash. ELEMIS is being sold by Steiner L…

Read the full story

Thursday, January 03, 2019

Suneva Grows Their Aesthetics Portfolio with New Deals

  Suneva® Medical, Inc., is partnering with Healeon Medical, Inc and Puregraft, LLC to add two new products to their aesthetics portfolio.  Healeon Medical…

Read the full story

Thursday, January 03, 2019

Bristol-Myers Squibb to Acquire Celgene

Bristol-Myers Squibb Company will acquire Celgene Corp. in a cash and stock transaction with an equity value of approximately $74 billion. The combined company with complementary areas of focus, will …

Read the full story

Wednesday, December 19, 2018

Glenmark Pharmaceuticals Enters US Branded Dermatology Segment

Glenmark Pharmaceuticals is entering into the branded dermatology segment in the United States. The branded portfolio for the US market will be developed and commercialized by Glenmark Thera…

Read the full story

Friday, November 30, 2018

Crown Laboratories Acquires Select Healthcare Brands from GlaxoSmithKline

Crown Laboratories, Inc. has acquired North American distribution rights of five OTC consumer brands from GlaxoSmithKline (GSK). The acquired portfolio includes: PanOxyl® daily acne wash…

Read the full story

Tuesday, November 20, 2018

Sinclair Pharma: Acquisition by Huadong Medicine Company Limited Now Complete

Huadong Medicine Company Limited (HMC) has acquired Sinclair Pharma Limited, a global aesthetics company headquartered in London, UK, in a deal worth approximately $222 million. HMC is a well-known Ch…

Read the full story

Wednesday, October 17, 2018

Aclaris Acquires Rhofade from Allergan

Aclaris Therapeutics, Inc. has entered into a definitive asset purchase agreement with Allergan Sales, LLC to acquire worldwide rights to Rhofade® (oxymetazoline hydrochloride) cream, 1% and addit…

Read the full story

Friday, October 05, 2018

EPI Acquires Rights to Cloderm Cream from Promius Pharma

EPI Health has acquired the rights rights to Cloderm® (clocortolone pivalate) Cream, 0.1% and its authorized generic from Promius Pharma, LLC, a wholly owned subsidiary of D…

Read the full story

Friday, September 28, 2018

Bellus Medical Now Part of Crown Laboratories

Crown Laboratories, Inc. and Hildred Capital Partners, LLC have acquired Bellus Medical. Bellus’s non-invasive offerings include the SkinPen, a medical grade microneedling device used exclusi…

Read the full story

Friday, September 21, 2018

Almirall Finalizes Acquisition of Allergan US Medical Dermatology Portfolio

Almirall, S.A. finalized its acquisition of products from Allergan's Medical Dermatology unit in the US: Aczone (dapsone), Tazorac (tazarotene), Azelex (azelaic acid), and Cordran Tape (flurandren…

Read the full story

Friday, September 14, 2018

Breaking Business News: Allergan Acquires Bonti

Allergan acquired Bonti, Inc., a privately held clinical-stage biotechnology company focused on the development and commercialization of novel, fast-acting neurotoxin programs for aesthetic and therap…

Read the full story

Tuesday, September 11, 2018

Business News: Candela Acquires Ellipse

Candela Corporation has acquired Ellipse, a Danish medical device company that manufactures and markets Intense Pulsed Light (IPL) and laser-based platforms for a wide variety of medical and aesthetic…

Read the full story
Load More